
Munich, Germany | full time | Job ID: 10543
About the Role:
We are seeking an experienced and strategic leader to spearhead critical initiatives that ensure compliance, enhance quality and foster innovation across global and site-specific functions.
In this role, you will lead critical change and transformation projects, e.g. the development and implementation of a comprehensive global Quality Management Review process that integrates both global and site-specific functions on all continents. As the key accountable leader for GMP Quality Assurance, you will drive Quality Management Systems (QMS) and GxP-compliant Change Management processes, ensuring alignment with regulatory standards and organizational goals.
Your Contribution:
A Good Match:
Your Benefits:
It's our priority to support you:
Apply now - We look forward to your application!
Apply to our Munich, Germanylocation by sending us your documents via our online form. For any questions, contact our talent acquisition team on: + 49 (0) 6131-9084-1291 (Monday-Friday from 1 PM to 3 PM CET).
Job ID 10543 (please always specify if you have any questions)
By submitting your application, you acknowledge that a background check will be conducted as part of the recruitment process in accordance with applicable laws and regulations. If you are considered for the position, BioNTech will conduct the background check through our service provider ‘HireRight’. You will be informed accordingly by your BioNTech-Recruiter.

Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases.
BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress.
BioNTech was founded in 2008 by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. At BioNTech, we have been conducting fundamental research of mRNA technologies in the field of individualized cancer medicine for more than a decade. Some of our colleagues, including our co-founders, have been researching and developing mRNA-based vaccines for more than 25 years.
Ready to join us on this journey? Explore the opportunities and become part of a team that aspires to turn bold ideas into real-world solutions: https://www.biontech.com/int/en/home/careers.html
🔗 Privacy Statement: https://www.biontech.com/int/en/home/data-privacy-statement.html
🔗 Imprint: https://www.biontech.com/int/en/home/imprint.html